Clenbuterol-Induced Myocarditis: A Case Report
  • Natassja Moriarty
    Department of Medicine, Furness General Hospital, Barrow-in-Furness, United Kingdom
  • Nadeem Attar
    Department of Cardiology, Furness General Hospital, Barrow-in-Furness, United Kingdom


Clenbuterol, myocardial infarction


Objective: We present a case of a 22-year-old bodybuilder diagnosed with myocarditis secondary to clenbuterol use.
Results: The patient was primarily managed conservatively by the discontinuation of clenbuterol and the temporary use of dual anti-platelets, beta-blockers and nitrates.
Conclusion: Clenbuterol is a long-acting beta-2 agonist primarily used in veterinary medicine. In recent years, it has been illegally marketed as a weight loss supplement because of its anabolic properties and is popular among fitness enthusiasts. It is our aim to use this case to underscore the adverse effects of this drug with hopes that tighter regulations will be instituted to stem its illegal distribution.



  • Daubert G, Mabasa V, Leung V, Aaron C. Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation. J Med Toxicol 2007;3(2):56–60.

  • Barry A, Graham M. Case report and review of clenbuterol cardiac toxicity. J Cardiol Cases 2013;8(4):131–133.

  • Kierzkowska B, Stanczyk J, Kasprzak J. Myocardial infarction in a 17-year-old body builder using clenbuterol. Circ J 2005;69(9):1144–1146.

  • Shafrir A, Leibowitz DW, Alcalai R, Elitzur Y, Muszkat M. Myocardial injury induced by the long acting beta2 adrenergic agonist clenbuterol. Cardiol Cardiovasc Med 2019;3(4):186–192.

  • Brett J, Dawson A, Brown J. Clenbuterol toxicity: a NSW Poisons Information Centre experience. Med J Aust 2014;200(4):219–221.

  • Huckins D, Lemons M. Myocardial ischemia associated with clenbuterol abuse: report of two cases. J Emerg Med 2013;44(2):444–449.

  • Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, Panhuyzen-Goedkoop N, et al. ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil 2006;13(5):687–694.

  • Burniston J, Ng Y, Clark W, Colyer J, Tan L, Goldspink D. Myotoxic effects of clenbuterol in the rat heart and soleus muscle. J Appl Physiol 2002;93(5):1824–1832.
  • Views: 1314
    HTML downloads: 517
    PDF downloads: 772

    Published: 2020-06-24
    Issue: 2020: Vol 7 No 9 (view)

    How to cite:
    Moriarty N, Attar N. Clenbuterol-Induced Myocarditis: A Case Report. EJCRIM 2020;7 doi:10.12890/2020_001662.